United States· US:70771-1842_905fd0b0-fd53-48f5-83ff-129a5f5f104c

oxcarbazepine

A oxcarbazepine product containing oxcarbazepine, registered in United States by Zydus Lifesciences Limited. The same ATC class is registered in 15 of our 19 countries.

ATC N03AF02Orange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedoxcarbazepineATCN03AF02REGISTER NO.US:70771-1842_905fd0b…PACKS LISTED3CHECKEDSeptember 12, 2026

Where it is registered

Oxcarbazepine is registered in 15 of 19 countries.

Countries holding a registration under ATC N03AF02 (oxcarbazepine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Oxcarbazepine · ATC N03AF02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxcarbazepine costs, country by country.

Normalised to the WHO defined daily dose (1 g), the median price runs from $0.56 in United States to $2.54 in Switzerland — a ×4.5 gap.

  • United States: $0.56 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Oxcarbazepine · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.54
  • FR France$1.08
  • IT Italy$0.73
  • US United States$0.56 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
oxcarbazepine
Manufacturer
Zydus Lifesciences Limited
Country
United States (US)
ATC code
N03AF02
ATC class
Oxcarbazepine
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 3

  • ndc11
    7077118421
    100 TABLET in 1 BOTTLE (70771-1842-1)
  • ndc11
    7077118424
    10 BLISTER PACK in 1 CARTON (70771-1842-4) / 10 TABLET in 1 BLISTER PACK
  • ndc11
    7077118425
    500 TABLET in 1 BOTTLE (70771-1842-5)

Regulatory notes

UNII (FDA substance ID)
VZI5B1W380
OXCARBAZEPINE
RxCUI 32624
Orange Book
A211747
DailyMed SPL labels
1 version tracked

Interactions

398 interactions on record for oxcarbazepine.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Oxcarbazepine · interactions on record

398 records

  • 8 severe
  • 263 moderate
  • 7 minor
  • 72 info

Most severe, free to view

  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Desogestrel and ethinylestradiolG03AA09severe
  • Drospirenone and ethinylestradiolG03AA12severe
  • EthinylestradiolG03CA01severe

48 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxcarbazepine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxcarbazepine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Trileptal
  • Belgium · Oxcarbazepine Viatris, Trileptal
  • Bulgaria · Трилептал
  • Cyprus · Oxcarbazepine Jubilant, Trileptal
  • Germany · Apydan Extent, Oxcarbazepin 1 A Pharma
  • Denmark · Apydan, Oxcarbazepin Jubilant
  • Estonia · Apydan, Trileptal
  • Spain · Oxcarbazepina Cinfa, Oxcarbazepina Normon
  • Finland · Apydan, Oxcarbazepin Orion
  • France · Oxcarbazepine Sandoz, Oxcarbazepine Viatris
  • United Kingdom (Northern Ireland) · Oxcarbazepine, Oxcarbazepine Amarox
  • Greece · Trileptal
  • Croatia · Trileptal
  • Hungary · Trileptal
  • Ireland · Trileptal
  • Iceland · Oxcarbazepine Jubilant, Trileptal
  • Italy · Oxcarbazepina Tecnigen, Tolep
  • Lithuania · Trileptal
  • Latvia · Trileptal
  • Netherlands · Oxcarbazepine Adoh, Oxcarbazepine Jubilant
  • Norway · Trileptal
  • Poland · Karbagen, Oxepilax
  • Portugal · Epilfarmo, Oxcarbazepina Biofarmoz
  • Romania · Trileptal
  • Sweden · Trileptal
  • Slovenia · Karbox
  • Slovakia · Trileptal

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bbe772bf-9a25-4dd1-b93c-bc2a584b9114
GET /v1/drugs/bbe772bf-9a25-4dd1-b93c-bc2a584b9114?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "VZI5B1W380",
    "rxcui": "32624",
    "inchikey": "CTRLABGOLIVAIY-UHFFFAOYSA-N",
    "display_name": "OXCARBAZEPINE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 3
  },
  "spl_meta": {
    "a18f591b-587e-4769-8ac2-9cfba0b82526": {
      "match": "brand_token",
      "title": "OXCARBAZEPINE (OXCARBAZEPINE) SUSPENSION [CAMBER PHARMACEUTICALS, INC.]",
      "spl_version": "3",
      "published_date": "2026-05-25"
    }
  },
  "productid": "70771-1842_905fd0b0-fd53-48f5-83ff-129a5f5f104c",
  "productndc": "70771-1842",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "211747",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": null,
        "strength": "150MG",
        "product_no": "001",
        "approval_date": "Jul 3, 2023"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": null,
        "strength": "300MG",
        "product_no": "002",
        "approval_date": "Jul 3, 2023"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": null,
        "strength": "600MG",
        "product_no": "003",
        "approval_date": "Jul 3, 2023"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "OXCARBAZEPINE",
  "proprietary_name": "oxcarbazepine",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA211747",
  "marketing_category": "ANDA",
  "nonproprietary_name": "oxcarbazepine",
  "start_marketing_date": "20250710",
  "active_numerator_strength": "150"
}

See everything about oxcarbazepine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.